Report copyright - PowerPoint Presentation · Primary Endpoint: Responder-HMB Reduction Q4:19/Q2:20. Placebo + placebo add -back. 100 mg + placebo add -back. 100 mg + add -back. 200 mg + placebo add
Please pass captcha verification before submit form